Human iPSC-derived ventricular-like cardiomyocytes
Ventricular cardiomyocytes generated with our standardized process are fully functional. Their relatively slow beat rate enables pacing for electrophysiological research. Base on this model, an array of functional assays can be developed and optimized providing relevant predictions of drug-induced responses.
Our team can generate cardiomyocytes from the iPSC that best fits your project or work with off-the-shelf Ncyte® vCardiomyocytes to support your projects.
- High purity ventricular-like cardiomyocytes
- Physiologically relevant
- Highly suitable for electrophysiological research
Do you want to buy Ncyte® vCardiomyocytes?
Do you need a custom cell model?
≥ 70% TNNT2 at day 3 of culture according user guide
≥ 4M viable cells at day 3 of culture according to user guide
Cell count, Viability, Identity (FACS), Functionality (MEA), Mycoplasma
Dry shipper, -180°C to -135°C
Vapor phase of liquid nitrogen
Ncyte® Cardiomyocyte Medium
Ncyte® vCardiomyocytes are characterized by flow cytometry to ensure a purity of ≥ 70% cardiac TroponinT (cTnT) positive cells after 3 days in culture following Ncardia’s user guide (Figure 2A). They typically express Myosin Light Chain 2v (MLC2v), indicating a ventricular-like phenotype (Figure 2B). Based on RNA-seq data, Ncyte® vCardiomyocytes express common sarcomere markers, such as TNNT2, while hiPSC and cardiac progenitor markers are silenced. Expression levels of additional genes are available upon request.
Ncyte® vCardiomyocytes exhibit well aligned myofibrils and intact structural sarcomere organization (See figure A). They typically express Myosin Light Chain 2v (MLC2v), indicating a ventricularlike phenotype. Based on RNA-seq data, Ncyte® vCardiomyocytes express common sarcomere markers, such as TNNT2, while hiPSC and cardiac progenitor markers are silenced. Expression levels of additional genes are available upon request.
Their action potential shows fast upstroke velocity and a well-defined plateau phase, resembling human ventricular cardiomyocytes (See figure B).
These make the Ncyte® vCardiomyocytes a physiologically relevant model for the phenotypic study of cardiac diseases. Our expert scientists can develop and execute predictive assays to support your drug discovery research in the cardiac field.
Ncyte® vCardiomyocytes present a relatively slow and uniform beating rate, which enables pacing for electrophysiological research (See top figure). Additionally, response to adrenergic stimulation with isoproterenol and ion channel blockers, nifedipine (L-type calcium channel blocker) and dofetilide (hERG channel blocker), is guaranteed for every batch (See figure A, B, C). Our scientific team is experienced in the electrophysiological analysis of Ncyte® vCardiomyocytes for safety and efficacy studies and can report the analyzed results to you.
Our work centers on a simple yet powerful premise:
When we combine deep iPSC knowledge, broad assay capabilities and a demonstrated ability to integrate the biology of human diseases into preclinical research, we can help drug developers make critical decisions earlier and with more confidence.
Human iPSC-derived atrial cardiomyocytesNeural Cortical Neurons
Human iPSC-derived cortical neuronsNeural Ncyte® Astrocytes
Human iPSC-derived astrocytesCardiac Ncyte® Endothelial cells
Human iPSC-derived vascular endothelial cellsNeural Ncyte® Neural Mix
Human iPSC-derived neurons and astrocytesCardiac Ncyte® vCardiomyocytes
Human iPSC-derived ventricular cardiomyocytesNeural Peripheral Neurons
Human iPSC-derived peripheral neuronsCardiac Vascular Smooth Muscle cells
Human iPSC-derived vascular smooth muscle cells